Austin, TX, United States of America

Andrew D Ellington

This inventor holds 32 USPTO granted patents and 27 published patent applications, plus 2 CIPO patents and 4 EPO patents, primarily in Biotechnology Research. Top assignees: The University of Texas System, Iowa State University Research Foundation Inc., Purdue Research Foundation. Active years: 2002-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew D Ellington. Retrieved from https://idiyas.com/inventor/andrew-d-ellington

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 32 

% Patents Active = 93.8

 

 

Average Co-Inventor Count = 3.8

ph-index = 6

Forward Citations = 219(Granted Patents)


Company Filing History:


Years Active: 2002-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Peptide Sequencing
Thermostable Enzymes
Microbiome Therapy
Transgenic Bacteria
Oligonucleotides
Nucleic Acid Amplification
Seleno-Biologics
Monoclonal Antibodies
Aptamers
Protein Stability
Metabolite Screening
32 patents (USPTO):Explore Patents

Title: Exploring the Innovations of Andrew D Ellington

Introduction: Andrew D Ellington is a prominent inventor based in Austin, TX, known for his significant contributions to molecular biology and biochemistry. With a remarkable total of 27 patents, Ellington has made substantial advancements in the fields of oligonucleotide technologies and reverse transcriptase methods, pushing the boundaries of scientific research and application.

Latest Patents: Among his latest innovations are two notable patents:

1. **Molecular Neighborhood Detection by Oligonucleotides** - This invention provides methods for molecular neighborhood detection of molecules, applying iterative proximity ligation or split-and-pool strategies to obtain critical positional information.

2. **Thermostable Reverse Transcriptase** - This patent encompasses methods and compositions related to the generation and use of proofreading reverse transcriptases, which are specifically designed to be thermophilic or hyperthermophilic. These polymerases are intended for RNA sequencing without the necessity for a cDNA intermediate, showcasing a significant leap in molecular research methodologies.

Career Highlights: Ellington’s career includes pivotal roles at the University of Texas System and Ambion, Inc., where he contributed to groundbreaking research and development in the life sciences sector. His expertise in biochemistry and molecular biology has facilitated numerous advancements within these institutions, highlighting his importance in the scientific community.

Collaborations: Throughout his career, Andrew D Ellington has collaborated with notable researchers such as Jimmy Gollihar and Edward M Marcotte. These collaborations have not only enriched his work but have also fostered an environment of innovation and progress in their respective fields.

Conclusion: Andrew D Ellington’s contributions to science, illustrated through his numerous patents and collaborations, reflect a commitment to advancing our understanding of molecular interactions and enzymatic processes. His work, characterized by its innovative approach and practical applications, continues to inspire future generations of scientists and inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…